
Oncology NEWS International
- Oncology NEWS International Vol 7 No 2
- Volume 7
- Issue 2
Thomas Jefferson Opens New Familial Colorectal Cancer Registry
PHILADELPHIA-Thomas Jefferson University’s new Familial Colorectal Cancer Registry is collecting information and blood and tissue samples from families with a higher-than-normal risk of colon cancer, to aid researchers looking for genetic markers of the disease and to provide genetic counseling and genetic testing, if appropriate, to participants.
PHILADELPHIAThomas Jefferson Universitys new Familial Colorectal Cancer Registry is collecting information and blood and tissue samples from families with a higher-than-normal risk of colon cancer, to aid researchers looking for genetic markers of the disease and to provide genetic counseling and genetic testing, if appropriate, to participants.
To date, 35 members of 24 families have been enrolled. Operations director Deborah Rose said she expects to have hundreds of new registry members in the next year.
Typically, a patient is referred to the registry by a physician, family member, or self-referral. To participate, patients may have either a personal or family history of a particular type of inherited colorectal cancer, such as familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer.
Others who are eligible include those who have had colorectal cancer diagnosed before age 30 and patients with a first-degree relative diagnosed with colorectal cancer before age 50.
For more information about the registry and clinical genetic testing, patients and physicians may call 1-800-JEFF-NOW (1-800-533-3669).
Articles in this issue
almost 28 years ago
Tobacco Companies Reach Settlement With Texas for $15.3 Billionalmost 28 years ago
Archives to Collect Info on Radiation Exposure Worldwidealmost 28 years ago
Few BRCA-1 Carriers Take Recommended Precautionsalmost 28 years ago
Lifelong Weight Control a Key to Breast Ca Preventionalmost 28 years ago
Eight-Year Prostate Brachytherapy Update Shows Good Resultsalmost 28 years ago
Patient Brochure on Breast Cancer Tumor Markersalmost 28 years ago
Gay Men’s Health Crisis Calls for HIV Reporting in New Yorkalmost 28 years ago
Single-Agent Taxanes in Advanced Breast Cancer: A Commentaryalmost 28 years ago
ODAC Declines to Vote on DepoCyt FDA Recommendationalmost 28 years ago
Photofrin Approved for Early-Stage Lung CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.




















































































